Goshajinkigan reduces bortezomib-induced mechanical allodynia in rats: Possible involvement of kappa opioid receptor

Hitomi Higuchi, Shota Yamamoto, Soichiro Ushio, Takehiro Kawashiri, Nobuaki Egashira

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

In the present study, we investigated the effect of a Kampo medicine Goshajinkigan (GJG) on the bortezomib-induced mechanical allodynia in von Frey test in rats. The single administration of tramadol (10 mg/kg), GJG (1.0 g/kg) and its component processed Aconiti tuber (0.1 g/kg) significantly reversed the reduction in withdrawal threshold by bortezomib. These effects were abolished by the intrathecal injection of nor-binaltorphimine (10 μg/body), kappa opioid receptor antagonist. These findings suggest that kappa opioid receptor is involved in the effect of GJG on the bortezomib-induced mechanical allodynia.

Original languageEnglish
Pages (from-to)196-199
Number of pages4
JournalJournal of Pharmacological Sciences
Volume129
Issue number3
DOIs
Publication statusPublished - Nov 1 2015
Externally publishedYes

Keywords

  • Bortezomib
  • Goshajinkigan
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'Goshajinkigan reduces bortezomib-induced mechanical allodynia in rats: Possible involvement of kappa opioid receptor'. Together they form a unique fingerprint.

Cite this